Wannee Nitiyanant

Wannee Nitiyanant

Auto-generated profile, based on publicly available information

Wannee Nitiyanant

Siriraj Diabetes Center of Excellence, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2020 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
PDPrapai Dejkhamron
Prapai Dejkhamron
JSJeerunda Santiprabhob
Jeerunda Santiprabhob
SLSupawadee Likitmaskul
Supawadee Likitmaskul
CDChaicharn Deerochanawong
Chaicharn Deerochanawong
PRPetch Rawdaree
Petch Rawdaree
WNWannee Nitiyanant
Wannee Nitiyanant
Aims/Introduction: The Thai Type 1 Diabetes and Diabetes Diagnosed Before Age 30 Years Registry, Care and Network was established in 2014 and involved 31 hospitals. The objective of the registry was to evaluate glycemic control and complications of patients with type 1 diabetes.Materials and Methods: Patients’ demographics, clinical data, frequencies of daily self‐monitoring of blood glucose (SMBG), glycemic control and complications were collected.Results: Among the 1,907 type 1 diabetes patients, the mean age was 21.2 ± 11.3 years. The mean glycated hemoglobin level was 9.35 ± 2.41%, with significant variations among age groups (P < 0.001). Conventional insulin treatment and intensive insulin treatment were used in 43 and 57% of patients, respectively. Mean glycated hemoglobin levels were significantly higher in patients treated with conventional insulin treatment compared to those treated with intensive insulin treatment (9.63 ± 2.34 vs 9.17 ± 2.46%, P = 0.002). Compared to the conventional insulin treatment group, significantly more patients in the intensive insulin treatment group achieved good glycemic control (P < 0.001), and fewer had diabetic retinopathy (P = 0.031). The prevalence of microvascular complications increased significantly with age (P < 0.001). Multivariate analysis showed good glycemic control to be associated with age 25 to <45 years, intensive insulin treatment with SMBG three or more times daily and diabetes duration of 1 to <5 years.Conclusions: Most Thai type 1 diabetes patients were not meeting the recommended glycemic target. As a result of this study, the national program to improve the quality of diabetes treatment and education has been implemented, and the results are ongoing.

1 May 2022 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
LPLukana Preechasuk
Lukana Preechasuk
STSuchavadee Tantasuwan
Suchavadee Tantasuwan
SLSupawadee Likitmaskul
Supawadee Likitmaskul
JSJeerunda Santiprabhob
Jeerunda Santiprabhob
OLOrnsuda Lertbannaphong
Ornsuda Lertbannaphong
RLRaweewan Lertwattanarak
Raweewan Lertwattanarak
Purpose: This study aimed to investigate the clinical characteristics, glycemic control, and microvascular complications compared between young-onset type 1 (T1DM) and type 2 diabetes (T2DM) patients at Siriraj Hospital. Patients and Methods: We collected demographic, clinical, glycemic control, and microvascular complication data of young-onset (onset < 30 years of age) T1DM and T2DM patients at our center using February 2019-December 2020 data from the Thai Type 1 Diabetes and Diabetes diagnosed Age before 30 years Registry, Care and Network (T1DDAR CN). Results: Of 396 patients, 76% had T1DM and 24% had T2DM. At diagnosis, T1DM were significantly younger (9.7± 5.4 vs 16.9± 6.4 years, p< 0.001), had a lower body mass index (17.2± 4.1 vs 30.8± 7.9 kg/m2, p< 0.001), higher prevalence of diabetic ketoacidosis (DKA) (66.1% vs 13.7%, p< 0.001), and higher HbA1c level (12.8± 2.6% vs 10.9± 3.1%, p=0.002) compared to T2DM. Regarding glycemic control, the mean HbA1c at registry enrollment did not differ between groups (T1DM 8.3± 1.8% vs T2DM 8.1± 2.2%, p=0.303), but T1DM achieved HbA1c < 7% significantly less than T2DM (19.3% vs 47.8%, p< 0.001). T1DM showed deterioration of glycemic control during 10– 20 years of age, and gradually improved during 20– 30 years of age, whereas patients with T2DM showed progressive worsening of glycemic control over time. Concerning microvascular complications, the prevalence of diabetic retinopathy (10.6% vs 9%, p=0.92) and diabetic neuropathy (3.4% vs 5.5%, p=0.514) between T1DM and T2DM was not significantly different. However, T2DM had a significantly higher prevalence of diabetic nephropathy (T1DM 10.1% vs T2DM 40.2%, p< 0.001) that developed within a significantly shorter duration of diabetes (T1DM 11.0± 6.8 vs T2DM 4.3± 5.1 years, p< 0.001) compared to T1DM. Conclusion: T1DM had a significantly high prevalence of DKA at presentation, and most T1DM did not achieve the glycemic target, especially during adolescence. T2DM had a significantly higher prevalence of diabetic nephropathy that developed within a shorter duration of diabetes compared to T1DM.

26 January 2020 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
LPLukana Preechasuk
Lukana Preechasuk
JSJeerunda Santiprabhob
Jeerunda Santiprabhob
ASApiradee Sriwijitkamol
Apiradee Sriwijitkamol
RLRaweewan Lertwattanarak
Raweewan Lertwattanarak
WSWeerachai Srivanichakorn
Weerachai Srivanichakorn
SLSupawadee Likitmaskul
Supawadee Likitmaskul
Click on the article title to read more.